Literature DB >> 19637987

Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease.

Wei Mo1, Jian-Ting Zhang.   

Abstract

Human ATP-binding cassette transporters (ABC transporter) belong to an extremely important superfamily of membrane transporters. They use energy from ATP hydrolysis to transport a wide variety of substrates across the cellular membrane. Due to the physiological and pharmacological importance of their diverse substrates, ABC transporters have been shown to have close relationship with various human diseases such as cystic fibrosis and multi-drug resistance in cancer chemotherapy. While it has been thought traditionally that functional ABC transporters exist as monomeric full or dimeric half transporters, emerging evidence indicates that some ABC transporters oligomerize on cellular membranes and this oligomerization seems to have functional relevance. Therefore, this oligomerization process might be a promising drug target for ABC transporter-related human diseases, especially in overcoming multi-drug resistance in cancer chemotherapy. In this review, we perform a critical analysis of the past studies on the oligomerization of ABC transporters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637987     DOI: 10.1517/17425250903124371

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  12 in total

1.  Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

Authors:  Natalia Grañé-Boladeras; Christopher M Spring; W J Brad Hanna; Marçal Pastor-Anglada; Imogen R Coe
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

2.  YCF1-mediated cadmium resistance in yeast is dependent on copper metabolism and antioxidant enzymes.

Authors:  Wenzhong Wei; Nathan Smith; Xiaobin Wu; Heejeong Kim; Javier Seravalli; Oleh Khalimonchuk; Jaekwon Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-25       Impact factor: 8.401

Review 3.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

4.  miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.

Authors:  Huanxin Liu; Xiaoxia Wu; Jie Huang; Juan Peng; Linlang Guo
Journal:  Int J Exp Pathol       Date:  2015-06-24       Impact factor: 1.925

5.  Transmembrane domain oligomerization propensity determined by ToxR assay.

Authors:  Catherine Joce; Alyssa Wiener; Hang Yin
Journal:  J Vis Exp       Date:  2011-05-26       Impact factor: 1.355

Review 6.  Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Authors:  Jiye Yin; Jianting Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

7.  Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerization.

Authors:  Catherine Joce; Alyssa A Wiener; Hang Yin
Journal:  Biochim Biophys Acta       Date:  2011-07-23

8.  Tonoplast-localized Abc2 transporter mediates phytochelatin accumulation in vacuoles and confers cadmium tolerance.

Authors:  David G Mendoza-Cózatl; Zhiyang Zhai; Timothy O Jobe; Garo Z Akmakjian; Won-Yong Song; Oliver Limbo; Matthew R Russell; Volodymyr I Kozlovskyy; Enrico Martinoia; Olena K Vatamaniuk; Paul Russell; Julian I Schroeder
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

9.  Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells.

Authors:  Hui Peng; Jing Qi; Zizheng Dong; Jian-Ting Zhang
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

10.  Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.

Authors:  Wenji Zhang; Yang Yang; Zizheng Dong; Zhi Shi; Jian-Ting Zhang
Journal:  J Biol Chem       Date:  2019-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.